BHVN
Biohaven Ltd.
NYSE · Healthcare · Biotechnology · US
$11.35
+5.29%Leverage
- Debt / equity
- 24.30x
- Net debt / equity
- 4.83x
- Debt / assets
- 0.80x
- Debt / EBITDA
- -0.52x
- Net debt / EBITDA
- -0.10x
Liquidity & coverage
- Current ratio
- 4.73x
- Quick ratio
- 4.73x
- Cash ratio
- 4.28x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $233.9M
Cash & dividend
- FCF / debt
- -1.72x
- Cash flow / debt
- -1.72x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026